Serge Muyldermans

USPTO Granted Patents = 9 (Patent Applications = 4)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 36(Granted Patents)

Location History:

Sint-Genesius-Rode, BE (2010)
Hoelaart, BE (2015)
Hoeilaart, BE (2002 - 2022)

Company Filing History:

6 out of 185

Vrije Universiteit Brussel

Katholieke Universiteit Leuven, Ku Leuven R&d

patents

4. 1 out of 44

Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw

patents

5. 1 out of 1

Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw

patent

6. 1 out of 5,089

Centre National De La Recherche Scientifique

patents

7. 1 out of 170

Universitéde Strasbourg

patents

8. 1 out of 223

Institut National De La Recherche Agronomique

patents

9. 1 out of 1

Institut Francais De La Vigne Et Du Vin

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11453886 - Virus-like particles and uses thereof (2022-09-27),

2. 10377834 - Single domain antibodies capable of modulating BACE activity (2019-08-13),

3. 10023629 - Anti-influenza antibody (2018-07-17),

4. 9908943 - Single domain antibodies capable of modulating BACE activity (2018-03-06),

5. 9156905 - Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof (2015-10-13),

6. 8568717 - Single domain antibodies capable of modulating BACE activity (2013-10-29),

7. 8097251 - Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof (2012-01-17),

8. 7655759 - Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains (2010-02-02),

9. 6479280 - Recombinant phages capable of entering host cells via specific interaction with an artificial receptor (2002-11-12),

Title: The Innovative Contributions of Serge Muyldermans

Introduction

Serge Muyldermans is a notable inventor based in Hoeilaart, Belgium. He has made significant contributions to the fields of pharmaceuticals and biotechnology, holding a total of nine patents. His work primarily focuses on the development of innovative solutions for various medical applications.

Latest Patents

Among his latest patents is the invention of virus-like particles and their uses. This invention relates to GFLV virus-like particles and their applications in pharmaceutical, agro, and veterinary fields. Another significant patent involves single domain antibodies capable of modulating BACE activity. This patent describes single variable-domain antibodies derived from camelids that specifically bind to BACE1 and inhibit its activity. These antibodies have potential applications in research and medical fields, particularly in the treatment of Alzheimer's disease.

Career Highlights

Serge Muyldermans has worked with esteemed institutions such as Vrije Universiteit Brussel and VIB VZW. His career is marked by a commitment to advancing scientific knowledge and developing practical applications for his inventions.

Collaborations

He has collaborated with notable colleagues, including Bart De Strooper and Els Marjaux, contributing to the advancement of research in his field.

Conclusion

Serge Muyldermans exemplifies the spirit of innovation through his patents and collaborations. His work continues to impact the fields of medicine and biotechnology significantly.

This text is generated by artificial intelligence and may not be accurate.